 |
|
Hyperprolactinemia—A Review of Recent Clinical Advances
Robert W. Kirby, MD;
Theodore A. Kotchen, MD;
E. Douglas Rees, MD
Arch Intern Med. 1979;139(12):1415-1419.
Abstract
Since the radioimmunoassay for serum prolactin became available eight years ago, prolactin has become a hormone of considerable clinical interest. An elevated serum prolactin concentration is the most frequent hormone marker for pituitary tumors. Secreted in excess, prolactin causes dysfunction of the hypothalamic-pituitary axis, the gonads, and the adrenal cortex. In women, menstrual disturbances, galactorrhea, infertility, and hirsutism result. Impotence, oligospermia, and decreased libido are common in men. These metabolic abnormalities attributed to prolactin excess are corrected when prolactin concentrations are lowered by either medical or surgical therapy. The availability of effective therapy mandates early recognition and proper management of the patient with hyperprolactinemia.
(Arch Intern Med 139:1415-1419, 1979)
Author Affiliations
From the Department of Medicine, University of Kentucky, Albert B. Chandler Medical Center, Lexington, Ky. Dr Kirby is now with the Department of Endocrinology, Carle Clinic Association, Urbana, Ill.
Footnotes
Accepted for publication April 25, 1979.
Reprint requests to the Department of Endocrinology, Carle Clinic Association, 602 W University Ave, Urbana, IL 61801 (Dr Kirby).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Identification of Mammosomatotrophs in the Turkey Hen Pituitary: Increased Abundance during Hyperprolactinemia
Ramesh et al.
Endocrinology 1998;139:781-786.
ABSTRACT
| FULL TEXT
|
